[1] 李异,田沂,陈军,等.乙型肝炎相关性慢加急性肝衰竭的治疗策略.中华临床医师杂志(电子版),2015,9(10):1774-1777. [2]中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018 年版). 实用肝脏病杂志,2019,22(2): 164-171. [3] Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology, 2013, 144 (7):1426-1437. [4] Barretor H, Fagundesc JG,Guevaram HA,et a1.Type-l hepatorenal syndrome associated with infections in cirrhosis:natural history,outcome of kidney function,and survival.Hepatology,2014,59(4):1505-1513. [5] Sozinov AS. Systemic endotoxemia during chronic viral hepatitis. Bull Exp Biol Med, 2002, 133(2): 153-155. [6] 王瑶,龚作炯.肝衰竭过程中乙酰化调控和细胞焦亡.世界华人消化杂志,2018,26(11):633-638+630. [7] Zhang Q,Yang F,Li X,et a1.Trichostatin ainhibits inflammation in phorbol myristate acetate-induced macrophages by regulating the acetylation of histone and/or non—histone proteins.Mol Med Rep, 2016,13(1):845-852. [8] Steetz K, Leifeld L, Grundmann D, et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology, 2000, 119(2): 446-460. [9] 李晓东,徐东平.HBV相关慢加急性肝衰竭免疫病理发病机制研究进展.实用肝脏病杂志,2015,18(3):317-320. [10] Hu YY, Dai JJ, Zong GZ, et al. Restoration of p53 acetylation by HDAC inhibition permits the necrosis/apoptosis switch of pancreatic ainar cell during experimental pancreatitis in mice. J Cell Physiol, 2019, 234(12):21988-21998. [11] Marumo T,Hishikawa K,Yoshikawa M,et al. Histone deacetylase modulates the proinflammatory and fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol, 2010,298(1): 133-141. [12] Sarin SK,Choudhury A. Acute-on-chronic liver failure: terminology,mechanisms and management. Nat Rev Gastroenterol Hepatol,2016, 13(3):131-149. [13] Monneret C. Histone deacetylase inhibitors. Eur J Med Chem,2005,40: 1-13. [14] Chrun ES, Modolo F, Daniel FI. Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis. Pathol Res Pract , 2017, 213: 1329-1339. [15] 张海月,李汛,张倩,等.MS-275对急性肝衰竭小鼠肝脏的保护作用.中华临床感染病杂志,2016,9(4):349-354. [16] Cantley MD, Zannettino ACW, Bartold PM, et al. Histone deacetylases (HDAC) in physiological and pathological bone remodelling. Bone,2017, 95: 162-174. [17] Zhang L, Wan J, Jiang R, et al. Protective effects of trichostatin A on liver injury in septic mice. Hepatol Res, 2009, 39(9): 931-938. [18] Leoni F, Fossati G, Lewis EC, et al. The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo. Mol Med, 2005, 11(1/12):1-15. |